Lilly announces acquisition of Ventyx Biosciences for around $1.2bn
Multiple Ventyx drugs are currently in phase 2 development for inflammatory disease
Read More
Section: Sales
UK and US agree on landmark pharma pricing tariff deal
US tariffs on UK-produced pharmaceuticals will remain at zero for three years
Read More
Pfizer and Metsera agree on merger after bidding war between Pfizer and Novo Nordisk
The Pfizer bid was chosen by Metsera after a concern was raised about US antitrust laws regarding the Novo Nordisk offer
Read More
Sandoz to acquire Just-Evotec Biologics to strengthen biosimilar development and manufacturing capabilities
Acquisition will add in-house continuous manufacturing expertise and expand Sandoz’s biosimilar production capacity
Read More
Novo Nordisk reports sales growth in 2025 as R&D pipeline advances
Growth driven by increased sales in diabetes and obesity markets
Read More